Europe Antibiotics Market Size & Outlook, 2023-2030
Europe antibiotics market, 2018-2030 (US$M)
Related Markets
Europe antibiotics market highlights
- The Europe antibiotics market generated a revenue of USD 10,970.2 million in 2023.
- The market is expected to grow at a CAGR of 3.3% from 2024 to 2030.
- In terms of segment, cell wall synthesis inhibitors was the largest revenue generating action mechanism in 2023.
- RNA Synthesis Inhibitors is the most lucrative action mechanism segment registering the fastest growth during the forecast period.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 10,970.2 million |
| Market revenue in 2030 | USD 13,758.1 million |
| Growth rate | 3.3% (CAGR from 2023 to 2030) |
| Largest segment | Cell wall synthesis inhibitors |
| Fastest growing segment | RNA Synthesis Inhibitors |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors |
| Key market players worldwide | AbbVie Inc, Pfizer Inc, Novartis AG ADR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Lupin, Viatris Inc, Melinta Therapeutics, Cipla Ltd DR, Shionogi & Co Ltd, GSK PLC, Kyorin Pharmaceutical, Nabriva Therapeutics |
Other key industry trends
- In terms of revenue, Europe region accounted for 21.5% of the global antibiotics market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 31,962.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibiotics Market Scope
Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe antibiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibiotics market will help companies and investors design strategic landscapes.
Cell wall synthesis inhibitors was the largest segment with a revenue share of 51.3% in 2023. Horizon Databook has segmented the Europe antibiotics market based on cell wall synthesis inhibitors, protein synthesis inhibitors, dna synthesis inhibitors, rna synthesis inhibitors, mycolic acid inhibitors covering the revenue growth of each sub-segment from 2018 to 2030.
- Europe Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2018-2030)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
- Europe Antibiotics Type Outlook (Revenue, USD Million, 2018-2030)
- Branded Antibiotics
- Generic Antibiotics
- Europe Antibiotics Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- 7-ACA
- Others
Reasons to subscribe to Europe antibiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe antibiotics market databook
-
Our clientele includes a mix of antibiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe antibiotics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe antibiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe antibiotics market size, by country, 2018-2030 (US$M)
Europe Antibiotics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
